Recent Updates — BIVI

BioVie Inc. entered into a sales agreement with A.G.P./Alliance Global Partners on September 11, 2026, authorizing the issuance and sale of up to $6,464,341 in shares of Class A common stock through an at-the-market offering. The company will pay the agent a commission equal to 3.0% of gross proceeds and intends to use any net proceeds for general corporate purposes. BioVie Inc. operates in the biotechnology industry, focusing on drug discovery and development.